Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-16 4:05 pm Sale |
2021-09-07 | 13D | Forte Biosciences, Inc. FBRX |
Wagner Paul A. | 51,162 9.100% |
-39,720 (-43.71%) |
Filing History |
| 2021-09-13 5:12 pm Unchanged |
2021-09-02 | 13G | Forte Biosciences, Inc. FBRX |
Logos Global Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-05-18 4:30 pm Purchase |
2021-05-17 | 13G | Forte Biosciences, Inc. FBRX |
Point72 Asset Management, L.P. | 27,842 5.200% |
27,842 (New Position) |
Filing History |
| 2021-04-12 4:17 pm Sale |
2021-03-31 | 13G | Forte Biosciences, Inc. FBRX |
ArrowMark Colorado Holdings LLC | 55,783 10.320% |
-61,686 (-52.51%) |
Filing History |
| 2021-03-22 4:45 pm Purchase |
2021-03-12 | 13G | Forte Biosciences, Inc. FBRX |
Perceptive Advisors LLC | 28,000 5.200% |
28,000 (New Position) |
Filing History |
| 2021-02-16 3:20 pm Purchase |
2020-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Steven Michael Oliveira | 26,043 5.100% |
3,600 (+16.04%) |
Filing History |
| 2021-02-12 4:48 pm Purchase |
2020-12-31 | 13G | Forte Biosciences, Inc. FBRX |
ORBIMED ADVISORS LLC | 25,431 4.740% |
25,431 (New Position) |
Filing History |
| 2021-02-12 4:11 pm Purchase |
2020-12-31 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 53,770 9.990% |
10,171 (+23.33%) |
Filing History |
| 2021-02-01 2:23 pm Purchase |
2020-12-31 | 13G | Forte Biosciences, Inc. FBRX |
FRANKLIN RESOURCES INC BEN |
42,155 8.200% |
42,155 (New Position) |
Filing History |
| 2020-09-01 09:10 am Purchase |
2020-08-28 | 13G | Forte Biosciences, Inc. FBRX |
Steven Michael Oliveira | 22,443 5.010% |
22,443 (New Position) |
Filing History |
| 2020-07-10 2:56 pm Purchase |
2020-06-30 | 13G | Forte Biosciences, Inc. FBRX |
ArrowMark Colorado Holdings LLC | 117,468 27.190% |
117,468 (New Position) |
Filing History |
| 2020-07-10 10:48 am Purchase |
2020-06-30 | 13G | Forte Biosciences, Inc. FBRX |
BlackRock Inc. BLK |
1,978 0.500% |
1,978 (New Position) |
Filing History |
| 2020-06-25 5:13 pm Purchase |
2020-06-15 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 43,599 9.990% |
43,599 (New Position) |
Filing History |
| 2020-06-25 4:16 pm Purchase |
2020-06-15 | 13D | Forte Biosciences, Inc. FBRX |
Wagner Paul A. | 90,882 21.040% |
90,882 (New Position) |
Filing History |